This generic
clearance for FDA customer satisfaction surveys is approved for 3
years under the following conditions: 1) FDA shall submit memos for
individual surveys (e.g., statement of need, intended use of
information, description of respondents, information collection
procedures, justification for incentives and estimated burden). 2)
OMB will respond with clearance or questions within 10 working days
3) OMB and FDA will jointly evaluate the generic clearance upon
resubmission in 3 years. Upon resubmission, FDA will provide a
summary of each collection approved under the generic clearance
(e.g., use of information).
Inventory as of this Action
Requested
Previously Approved
07/31/2011
07/31/2011
07/31/2011
8,600
0
6,000
2,600
0
1,800
0
0
0
This agreeement will allow FDA to
conduct customer satisfaction surveys to gain important feedback
from regulated entities such as food processors, cosmetic, drug,
biologic, and medical device manufacturers as well as consumers and
health professionals and partner surveys of the State and local
governments.
EO: EO
12862 Name/Subject of EO: Setting Customer Service Standards
Daniel Gitteson 3017965156
daniel.gitteson@fda.hhs.gov
No
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.